These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 16779730)

  • 61. Vaccine-induced opsonophagocytic immunity to Neisseria meningitidis group B.
    Plested JS; Granoff DM
    Clin Vaccine Immunol; 2008 May; 15(5):799-804. PubMed ID: 18353918
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Naturally-acquired immunity to Neisseria meningitidis group A.
    Amir J; Louie L; Granoff DM
    Vaccine; 2005 Jan; 23(8):977-83. PubMed ID: 15620470
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Should we be doing more to prevent Group C meningococcal infection in school age children? How can we decide?
    Johnstone T
    J Public Health Med; 1999 Dec; 21(4):480; author reply 481. PubMed ID: 11469376
    [No Abstract]   [Full Text] [Related]  

  • 64. Protection Against Meningococcal Challenge Afforded Mice After Immunization with Typhoid-Paratyphoid Vaccine USP.
    Banknieder AR; Devine LF; Faust CA
    Infect Immun; 1973 Mar; 7(3):361-5. PubMed ID: 16558076
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Update on bacterial pathogens: virulence and resistance.
    Cercenado E; Garau J; Almirante B; Ramón Azanza J; Cantón R; Cisterna R; María Eiros J; Fariñas C; Fortún J; Gudiol F; Mensa J; Pachón J; Pascual Á; Luis Pérez J; Rodríguez A; Sánchez M; Vila J
    Enferm Infecc Microbiol Clin; 2008 Apr; 26():3-21. PubMed ID: 38620184
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Immunogenicity and safety of meningococcal C conjugate vaccine in children and adolescents infected and uninfected with HIV in Rio de Janeiro, Brazil.
    Frota AC; Milagres LG; Harrison LH; Ferreira B; Menna Barreto D; Pereira GS; Cruz AC; Pereira-Manfro W; de Oliveira RH; Abreu TF; Hofer CB
    Pediatr Infect Dis J; 2015 May; 34(5):e113-8. PubMed ID: 25876102
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Inhibition of the alternative pathway of nonhuman infant complement by porin B2 contributes to virulence of Neisseria meningitidis in the infant rat model.
    Lewis LA; Vu DM; Granoff DM; Ram S
    Infect Immun; 2014 Jun; 82(6):2574-84. PubMed ID: 24686052
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines.
    Pollard AJ; Perrett KP; Beverley PC
    Nat Rev Immunol; 2009 Mar; 9(3):213-20. PubMed ID: 19214194
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Bactericidal antibody responses elicited by a meningococcal outer membrane vesicle vaccine with overexpressed factor H-binding protein and genetically attenuated endotoxin.
    Koeberling O; Seubert A; Granoff DM
    J Infect Dis; 2008 Jul; 198(2):262-70. PubMed ID: 18505380
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effectiveness of meningococcal serogroup C vaccine programmes.
    Borrow R; Abad R; Trotter C; van der Klis FR; Vazquez JA
    Vaccine; 2013 Sep; 31(41):4477-86. PubMed ID: 23933336
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Antibody persistence after serogroup C meningococcal conjugate immunization of United Kingdom primary-school children in 1999-2000 and response to a booster: a phase 4 clinical trial.
    Perrett KP; Winter AP; Kibwana E; Jin C; John TM; Yu LM; Borrow R; Curtis N; Pollard AJ
    Clin Infect Dis; 2010 Jun; 50(12):1601-10. PubMed ID: 20459323
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Antibody persistence 3 years after immunization of adolescents with quadrivalent meningococcal conjugate vaccine.
    Vu DM; Welsch JA; Zuno-Mitchell P; Dela Cruz JV; Granoff DM
    J Infect Dis; 2006 Mar; 193(6):821-8. PubMed ID: 16479517
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evidence for Rise in Meningococcal Serogroup C Bactericidal Antibody Titers in the Absence of Booster Vaccination in Previously Vaccinated Children.
    Badahdah AM; Khatami A; Tashani M; Rashid H; Booy R
    Pediatr Infect Dis J; 2018 Mar; 37(3):e66-e71. PubMed ID: 29227467
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Investigation of serum bactericidal activity in childhood and adolescence 3-6 years after vaccination with a single dose of serogroup C meningococcal conjugate vaccine.
    Sakou II; Tzanakaki G; Tsolia MN; Sioumala M; Barbouni A; Kyprianou M; Papaevangelou V; Tsitsika A; Blackwell CC; Kafetzis D; Kremastinou J
    Vaccine; 2009 Jul; 27(33):4408-11. PubMed ID: 19500554
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effectiveness analyses may underestimate protection of infants after group C meningococcal immunization.
    Vu DM; Kelly D; Heath PT; McCarthy ND; Pollard AJ; Granoff DM
    J Infect Dis; 2006 Jul; 194(2):231-7. PubMed ID: 16779730
    [TBL] [Abstract][Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.